Prestige Consumer Healthcare Inc. $PBH Shares Purchased by Raymond James Financial Inc.

Key Points

• Raymond James Financial Inc. increased its holdings in Prestige Consumer Healthcare Inc. by 4.2%, owning 568,178 shares valued at approximately $48.85 million as of the latest SEC filing.
• Prestige Consumer Healthcare recently reported earnings per share (EPS) of $0.95, which fell short of analysts’ expectations and represented a 6.6% decline in revenue compared to the previous year.
• Analysts have mixed ratings for Prestige Consumer Healthcare, with a consensus rating of "Moderate Buy" and a target price set at $93.33.

Raymond James Financial Inc. lifted its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 4.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 568,178 shares of the company's stock after purchasing an additional 22,738 shares during the period. Raymond James Financial Inc. owned about 1.15% of Prestige Consumer Healthcare worth $48,846,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of PBH. Opal Wealth Advisors LLC purchased a new stake in Prestige Consumer Healthcare during the 1st quarter valued at about $38,000. McIlrath & Eck LLC grew its stake in Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after acquiring an additional 154 shares in the last quarter. Johnson Financial Group Inc. purchased a new stake in Prestige Consumer Healthcare during the 4th quarter valued at about $93,000. Costello Asset Management INC purchased a new stake in Prestige Consumer Healthcare during the 1st quarter valued at about $112,000. Finally, Tower Research Capital LLC TRC grew its stake in Prestige Consumer Healthcare by 97.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 1,925 shares of the company's stock valued at $150,000 after acquiring an additional 950 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Up 1.0%

Shares of Prestige Consumer Healthcare stock traded up $0.64 during mid-day trading on Wednesday, hitting $67.05. The stock had a trading volume of 470,485 shares, compared to its average volume of 605,491. The firm has a 50-day moving average of $74.26 and a two-hundred day moving average of $80.83. Prestige Consumer Healthcare Inc. has a 12-month low of $62.95 and a 12-month high of $90.04. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The firm has a market cap of $3.30 billion, a P/E ratio of 15.74, a price-to-earnings-growth ratio of 2.10 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm had revenue of $249.53 million during the quarter, compared to analysts' expectations of $260.71 million. During the same period last year, the company earned $0.90 EPS. The business's quarterly revenue was down 6.6% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. Sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PBH has been the subject of several research reports. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Canaccord Genuity Group dropped their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Wall Street Zen cut shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.